| 03.06 12:56 | dpa-AFX: Edwards Lifesciences Stock Up With BD Deal To Buy Critical Care Product Unit For $4.2 Bln Cash |
| 03.06 12:37 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE FOR $4.2 BLN, SEES DEAL TO CLOSE BEFORE END OF CALENDAR YEAR |
| 03.06 12:37 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE; EXPECTS TO FUND ALL-CASH TRANSACTION WITH ABOUT $1 BLN OF CASH, $3.2 BLN OF NEW DEBT |
| 03.06 12:36 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE FOR $4.2 BLN, SEES DEAL IMMEDIATELY ACCRETIVE TO ALL KEY FINANCIAL MEASURES |
| 03.06 12:34 | dpa-AFX: *BD TO BUY EDWARDS LIFESCIENCES' CRITICAL CARE PRODUCT GROUP FOR $4.2 BLN IN CASH |
| 30.05 12:40 | dpa-AFX: *GOLDMAN STARTS BECTON. DICKINSON & CO, WITH 'BUY' - PRICE TARGET 274 USD |
| 30.05 12:40 | dpa-AFX: *GOLDMAN STARTET BECTON, DICKINSON & CO. MIT 'BUY' - ZIEL 274 USD |
| 02.05 12:56 | dpa-AFX: BD Lifts FY24 Earnings View In Line Or Above Market Estimates; Stock Up In Pre-market |
| 02.05 12:36 | dpa-AFX: Becton, Dickinson and Company Q2 Profit Increases, beats estimates |
| 02.05 12:36 | dpa-AFX: *BD Q2 EPS $1.85 VS $1.53 PRIOR YEAR |
| 02.05 12:36 | dpa-AFX: *BD Q2 ADJ EPS $3.17 VS $2.86 PRIOR YEAR |
| 02.05 12:35 | dpa-AFX: *BD RAISES FULL-YEAR ADJ. EPS GUIDANCE AND AFFIRMS ORGANIC REVENUE GROWTH GUIDANCE |
| 02.05 12:32 | dpa-AFX: *BD Q2 REVENUE $5.0 BLN INCREASE OF 4.6% AS REPORTED, 4.7% CURRENCY-NEUTRAL AND 5.7% ORGANIC |
| 30.04 22:18 | dpa-AFX: *BECTON, DICKINSON AND COMPANY (BDX) DECLARES QUARTERLY DIVIDEND OF $ 0.95, RECORD DATE 6/10/2024 |
| 05.04 13:10 | dpa-AFX: BD Announces Global Commercial Release Of New BD FACSDiscover S8 Cell Sorters |
| 05.04 12:52 | dpa-AFX: *BD ANNOUNCES GLOBAL COMMERCIAL RELEASE OF NEW CELL SORTERS |
| 02.04 03:14 | dpa-AFX: AngioDynamics Settles All Patent Litigation With C.R. Bard |
| 27.02 12:55 | dpa-AFX: *BD SAYS EVP AND PRESIDENT OF LIFE SCIENCES SEGMENT DAVE HICKEY WILL RETIRE, EFFECTIVE JULY 1 |
| 21.02 12:48 | dpa-AFX: *BD PARTNERS WITH CAMTECH HEALTH TO INCREASE ACCESS TO CERVICAL CANCER SCREENING IN SINGAPORE |
| 01.02 13:03 | dpa-AFX: BD Q1 Adj. EPS Tops View, Lifts FY24 Outlook; Stock Up In Pre-market |
|
|
